NCT06258252
Effect of Metabolic Dysfunction in Branched-chain Amino Acids on Cardiac Function in Patients With Sepsis
Effect of Metabolic Dysfunction in Branched-chain Amino Acids on Cardiac Function in Patients With Sepsis: an Observational Study
West China Hospital·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Sepsis
- Drug/Device/Intervention
- Effect of BCAAs metabolic dysfunction on cardiac function in sepsis
- Study type
- Observational
- Intervention type
- other
Sponsor & location
- Primary sponsor
- West China Hospital
Timeline & enrollment
- Phase
- N/A
- Start date
- Mar 15, 2024
- End date
- Mar 15, 2026
- Enrollment
- 50 participants
Primary outcome
The incidence of Sepsis induced cardiomyopathy
Summary
The current project was designed to examine the effects of BCAA metabolic dysfunction on
 cardiac function in septic patients.
ICD-10 classifications
Other sepsisSepsis, unspecifiedOther specified sepsisCandidal sepsisPuerperal sepsis
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06258252
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT06258252 through Pure Global AI's free database. This phase not specified trial is sponsored by West China Hospital and is currently Not yet recruiting. The study focuses on Sepsis. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.